BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9673785)

  • 1. Preparation and evaluation of micro-porous ethylcellulose capsule as oral sustained-release preparation of theophylline.
    Yoshikawa Y; Kawai A; Yasui H; Yoshikawa H; Takada K
    Biopharm Drug Dispos; 1998 Jul; 19(5):333-9. PubMed ID: 9673785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the properties of ethylcellulose-cellulose triacetate microcapsules containing theophylline prepared by different microencapsulation techniques.
    Wu JC; Jean WJ; Chen H
    J Microencapsul; 1994; 11(5):507-18. PubMed ID: 7815268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral sustained-release cisplatin capsule.
    Houjou T; Nakano K; Ike O; Wada H; Hitomi S; Shinmi Y; Danno N; Yoshikawa Y; Takada K
    J Pharm Pharmacol; 1996 May; 48(5):474-8. PubMed ID: 8799870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
    Roshdy MN; Schnaare RL; Sugita ET; Schwartz JB
    Pharm Dev Technol; 2002 May; 7(2):155-68. PubMed ID: 12066571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability studies of theophylline ethylcellulose microcapsules prepared by using ethylene-vinyl acetate copolymer as a coacervation-inducing agent.
    Lin SY; Yang JC
    J Pharm Sci; 1987 Mar; 76(3):219-23. PubMed ID: 3585738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
    Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
    J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
    Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
    Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.
    Niwa K; Takaya T; Morimoto T; Takada K
    J Drug Target; 1995; 3(2):83-9. PubMed ID: 7496731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microcapsule size and polyisobutylene concentration on the release of theophylline from ethylcellulose microcapsules.
    Sa B; Bandyopadhyay AK; Gupta BK
    J Microencapsul; 1996; 13(2):207-18. PubMed ID: 8999125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the properties of ethylcellulose microcapsules prepared by emulsion non-solvent addition method in the presence of non-solvent in polymer solution.
    Wu JC; Chen HY; Chen H
    J Microencapsul; 1994; 11(5):519-29. PubMed ID: 7815269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of ethylcellulose microcapsules containing theophylline by using emulsion non-solvent addition method.
    Chen H; Wu JC; Chen HY
    J Microencapsul; 1995; 12(2):137-47. PubMed ID: 7629656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of mixture of commercially available polymers as constituents of sustained-release microcapsules containing cefadroxil or theophylline.
    Uchida T; Yasutake T; Goto S
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):463-6. PubMed ID: 1606646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surelease as granulating liquid in preparation of sustained release matrices of ethylcellulose and theophylline.
    Afrasiabi Garekani H; Faghihnia Torshizi M; Sadeghi F
    Drug Dev Ind Pharm; 2015; 41(10):1655-60. PubMed ID: 25402967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation of theophylline using ethylcellulose: in vitro drug release and kinetic modelling.
    Lavasanifar A; Ghalandari R; Ataei Z; Zolfaghari ME; Mortazavi SA
    J Microencapsul; 1997; 14(1):91-100. PubMed ID: 8994078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline granule formulation prepared by the wet granulation method: comparison of in vitro dissolution profiles and estimation of in vivo plasma concentrations.
    Karasulu E; Apaydin S; Ince I; Tuglular I
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):291-8. PubMed ID: 17315541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ethylcellulose molecular weight on the properties of theophylline microspheres.
    Dashevsky A; Zessin G
    J Microencapsul; 1997; 14(3):273-80. PubMed ID: 9147278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ultraviolet light on the release of theophylline from ethylcellulose-based sustained-release microcapsules.
    Asker AF; Ferdous AJ
    PDA J Pharm Sci Technol; 1997; 51(3):125-9. PubMed ID: 9203826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.